Australia markets close in 3 hours 20 minutes

Cardiff Oncology, Inc. (CRDF)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.98000.0000 (0.00%)
At close: 04:00PM EDT
2.8800 -0.10 (-3.36%)
After hours: 07:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 133.32M
Enterprise value 68.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)218.26
Price/book (mrq)2.19
Enterprise value/revenue 111.68
Enterprise value/EBITDA -9.38

Trading information

Stock price history

Beta (5Y monthly) 1.88
52-week change 383.95%
S&P500 52-week change 324.52%
52-week high 36.4200
52-week low 30.9400
50-day moving average 34.1928
200-day moving average 32.4273

Share statistics

Avg vol (3-month) 3990.2k
Avg vol (10-day) 3435.62k
Shares outstanding 544.74M
Implied shares outstanding 644.74M
Float 841.35M
% held by insiders 17.55%
% held by institutions 122.03%
Shares short (15 May 2024) 44.62M
Short ratio (15 May 2024) 45.67
Short % of float (15 May 2024) 410.64%
Short % of shares outstanding (15 May 2024) 410.34%
Shares short (prior month 15 Apr 2024) 43.99M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Feb 2019
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 320 Feb 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,333.17%

Management effectiveness

Return on assets (ttm)-30.66%
Return on equity (ttm)-51.12%

Income statement

Revenue (ttm)610k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)147.00%
Gross profit (ttm)N/A
EBITDA -43.88M
Net income avi to common (ttm)-40.25M
Diluted EPS (ttm)-0.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)67.19M
Total cash per share (mrq)1.5
Total debt (mrq)2M
Total debt/equity (mrq)3.28%
Current ratio (mrq)5.91
Book value per share (mrq)1.36

Cash flow statement

Operating cash flow (ttm)-29.97M
Levered free cash flow (ttm)-17.7M